The BAL in the bacteriologic etiology in the COPD exacerbations

A. Scaramozzino, G. Porcino, G. Grippaldi (Reggio Calabria, Italy)

Source: Annual Congress 2005 - COPD - exacerbations II
Session: COPD - exacerbations II
Session type: Thematic Poster Session
Number: 1987
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Scaramozzino, G. Porcino, G. Grippaldi (Reggio Calabria, Italy). The BAL in the bacteriologic etiology in the COPD exacerbations. Eur Respir J 2005; 26: Suppl. 49, 1987

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Sputum biomarkers in COPD exacerbations
Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Year: 2011

Effect of sputum bacteriology on the prognosis of patients with acute exacerbations of bronchiectasis
Source: International Congress 2017 – COPD and weaning
Year: 2017

Pulmonary and systemic inflammation in patients with AECOPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013

The relation between pathogenic bacteriology in sputum and lung function in patients with acute exacerbation of COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 592s
Year: 2002

Microbiological and inflammatory characteristics of exacerbations in COPD patients with comorbid radiographic bronchiectasis
Source: International Congress 2019 – Bronchiectasis
Year: 2019

Does sputum, biochemical and radiological markers of infection correlate with antibiotic prescribing in acute exacerbations of COPD?
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014


Etiology of exacerbations in severe COPD patients with bronchial chronic colonization by pseudomonas
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013

Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD
Source: Eur Respir J 2012; 40: 1344-1353
Year: 2012



Sputum bacteriology in acute COPD exacerbations: correlation with FEV1 deterioration
Source: Eur Respir J 2001; 18: Suppl. 33, 189s
Year: 2001

Induced sputum cytology at different etiology of exacerbation of chronic obstructive bronchitis
Source: Eur Respir J 2002; 20: Suppl. 38, 543s
Year: 2002

An evaluation of exacerbations in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 89s
Year: 2004

Microbiological indicators from sputum of patients with exacerbation of COPD
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015


Analysis of microbiological colonization in COPD patients with or without bronchiectasis
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020


Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD
Source: Eur Respir J 2013; 41: 993-995
Year: 2013


Lung function and bacterial pathogens in sputum of patients with acute exacerbation of COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 408s
Year: 2004

Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis
Source: Eur Respir J 2012; 39: 1354-1360
Year: 2012



Significance of sputum purulence to guide antibiotic therapy in exacerbations of COPD
Source: Eur Respir J 2013; 41: 248
Year: 2013


Significance of sputum purulence to guide antibiotic therapy in exacerbations of COPD
Source: Eur Respir J 2013; 41: 248-249
Year: 2013


Changes in patients perception of dyspnoea, sputum volume and sputum purulence during treatment of chronic bronchitis exacerbations
Source: Eur Respir J 2001; 18: Suppl. 33, 213s
Year: 2001

Definition and aetiology of infective exacerbations of COPD
Source: Eur Respir Monogr 2013; 60: 58-67
Year: 2013